{
  "summary": {
    "timestamp": "2025-09-18T19:15:27.956658",
    "total_cases": 9,
    "successful_cases": 9,
    "success_rate": 1.0,
    "avg_parsing_accuracy": 0.5248677248677249,
    "avg_medication_accuracy": 0.376984126984127,
    "avg_risk_assessment_quality": 0.027777777777777776,
    "avg_latency_ms": 2815.437502331204,
    "safety_compliance_rate": 0.6666666666666666,
    "failed_cases": [],
    "safety_violations": [
      {
        "case_id": "ATC017",
        "violations": [
          "Complex case with no drug interaction warnings"
        ]
      },
      {
        "case_id": "ATC036",
        "violations": [
          "Complex case with no drug interaction warnings"
        ]
      },
      {
        "case_id": "ATC051",
        "violations": [
          "Complex case with no drug interaction warnings"
        ]
      }
    ]
  },
  "detailed_results": [
    {
      "case_id": "ATC001",
      "success": true,
      "latency_ms": 3393.6774730682373,
      "parsing_accuracy": 0.6666666666666666,
      "medication_accuracy": 0.6666666666666666,
      "risk_assessment_quality": 0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [],
            "contraindicated": [
              {
                "citations": [
                  "PMID:copd002",
                  "Chest 2018"
                ],
                "contraindication_reason": "Respiratory depression risk in COPD patients with limited respiratory reserve",
                "evidence_grade": "B",
                "generic_name": "Morphine",
                "justification": "Morphine causes dose-dependent respiratory depression. In COPD patients with baseline hypercapnia and reduced respiratory reserve, even small doses can precipitate respiratory failure.",
                "medication": "MORPHINE",
                "patient_factors": [
                  "COPD",
                  "Home oxygen therapy"
                ]
              },
              {
                "citations": [
                  "PMID:asthma005",
                  "BJA 2017"
                ],
                "contraindication_reason": "Potent airway irritant causing bronchospasm in reactive airway disease",
                "evidence_grade": "B",
                "generic_name": "Desflurane",
                "justification": "Desflurane has a pungent odor and irritates airways, triggering bronchospasm in asthmatic patients. Sevoflurane is the preferred volatile agent due to its bronchodilatory properties.",
                "medication": "DESFLURANE",
                "patient_factors": [
                  "Asthma",
                  "Reactive airway disease"
                ]
              }
            ],
            "draw_now": [
              {
                "citations": [
                  "PMID:albuterol009",
                  "GINA Guidelines 2022"
                ],
                "dose": "2.5 mg nebulized",
                "evidence_grade": "A",
                "generic_name": "Albuterol",
                "indication": "First-line bronchodilator for asthma exacerbation",
                "justification": "Beta-2 selective agonist provides rapid bronchodilation with minimal cardiac effects. Essential for treating perioperative bronchospasm in asthmatic patients.",
                "medication": "ALBUTEROL",
                "patient_factors": [
                  "Asthma",
                  "Risk of bronchospasm"
                ]
              },
              {
                "citations": [
                  "PMID:copd010",
                  "GOLD Guidelines 2023"
                ],
                "dose": "2.5-5 mg nebulized",
                "evidence_grade": "A",
                "generic_name": "Albuterol",
                "indication": "Bronchodilator for COPD exacerbation",
                "justification": "Beta-2 agonists remain first-line therapy for acute COPD exacerbations. Higher doses may be needed in COPD compared to asthma due to different pathophysiology.",
                "medication": "ALBUTEROL",
                "patient_factors": [
                  "COPD",
                  "Home oxygen therapy"
                ]
              },
              {
                "citations": [
                  "PMID:ipratropium011",
                  "Thorax 2021"
                ],
                "dose": "0.5 mg nebulized",
                "evidence_grade": "A",
                "generic_name": "Ipratropium",
                "indication": "Anticholinergic bronchodilator - synergistic with albuterol in COPD",
                "justification": "Anticholinergics are particularly effective in COPD due to increased cholinergic tone. Combined with beta-2 agonists, provides superior bronchodilation compared to either agent alone.",
                "medication": "IPRATROPIUM",
                "patient_factors": [
                  "COPD",
                  "Chronic bronchitis component"
                ]
              }
            ],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 1.0,
            "demographics": {
              "age_category": "AGE_1_5",
              "age_text": "5-year-old",
              "age_years": 5,
              "procedure": "TONSILLECTOMY",
              "sex": "SEX_MALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [
              {
                "category": "pulmonary",
                "confidence": 0.8,
                "evidence_text": "asthma",
                "plain_label": "Asthma",
                "severity_weight": 1.0,
                "token": "ASTHMA"
              },
              {
                "category": "pulmonary",
                "confidence": 0.8,
                "evidence_text": "Recent upper respiratory infection",
                "plain_label": "Recent upper respiratory infection (\u22642 weeks)",
                "severity_weight": 1.0,
                "token": "RECENT_URI_2W"
              },
              {
                "category": "airway",
                "confidence": 0.8,
                "evidence_text": "Obstructive sleep apnea",
                "plain_label": "Obstructive sleep apnea",
                "severity_weight": 1.0,
                "token": "OSA"
              },
              {
                "category": "pulmonary",
                "confidence": 0.8,
                "evidence_text": "inhaler",
                "plain_label": "Chronic obstructive pulmonary disease",
                "severity_weight": 1.0,
                "token": "COPD"
              },
              {
                "category": "pharmacological",
                "confidence": 0.85,
                "evidence_text": "albuterol",
                "plain_label": "Medication (albuterol)",
                "severity_weight": 1.0,
                "token": "BRONCHODILATORS"
              },
              {
                "category": "pharmacological",
                "confidence": 0.85,
                "evidence_text": "fluticasone",
                "plain_label": "Medication (fluticasone)",
                "severity_weight": 1.0,
                "token": "INHALED_STEROIDS"
              }
            ],
            "session_id": "hpi_2025-09-18T23:14:58.450369"
          },
          "recommendations": {
            "intraoperative": [
              {
                "action": "Avoid desflurane, prefer sevoflurane + deep extubation",
                "category": "Airway Management",
                "evidence": "Grade B - BJA Airway Guidelines",
                "priority": "moderate",
                "rationale": "Minimize bronchospasm triggers"
              },
              {
                "action": "Sevoflurane mask induction + TIVA maintenance",
                "category": "Pediatric Anesthesia",
                "evidence": "Grade A - Pediatric Anesthesia Society Guidelines",
                "priority": "moderate",
                "rationale": "Reduce emergence delirium in children"
              }
            ],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": [
              {
                "action": "Bronchodilator therapy + pulmonary function testing",
                "category": "Respiratory Optimization",
                "evidence": "Grade A - Global Initiative for Asthma 2021",
                "priority": "moderate",
                "rationale": "Optimize respiratory status before surgery"
              }
            ]
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udccb</span>\n                        Pre-operative Optimization\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Respiratory Optimization</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Bronchodilator therapy + pulmonary function testing\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Optimize respiratory status before surgery\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - Global Initiative for Asthma 2021\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\u2695\ufe0f</span>\n                        Intra-operative Management\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Airway Management</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Avoid desflurane, prefer sevoflurane + deep extubation\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Minimize bronchospasm triggers\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade B - BJA Airway Guidelines\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Pediatric Anesthesia</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Sevoflurane mask induction + TIVA maintenance\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Reduce emergence delirium in children\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - Pediatric Anesthesia Society Guidelines\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.07000000029802322,
                "baseline_risk": 0.07000000029802322,
                "category": "cardiovascular",
                "evidence_grade": "C",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Ventricular tachycardia/fibrillation",
                    "risk": 0.07000000029802322
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "7.0% risk of ventricular tachycardia/fibrillation",
                  "outcome": "VENTRICULAR_ARRHYTHMIA",
                  "outcome_label": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 3,
              "total_risk_factors": 6
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [
          "ASTHMA",
          "RECENT_URI_2W",
          "OSA",
          "COPD",
          "BRONCHODILATORS",
          "INHALED_STEROIDS"
        ],
        "recommended_medications": {
          "consider": [],
          "contraindicated": [
            {
              "citations": [
                "PMID:copd002",
                "Chest 2018"
              ],
              "contraindication_reason": "Respiratory depression risk in COPD patients with limited respiratory reserve",
              "evidence_grade": "B",
              "generic_name": "Morphine",
              "justification": "Morphine causes dose-dependent respiratory depression. In COPD patients with baseline hypercapnia and reduced respiratory reserve, even small doses can precipitate respiratory failure.",
              "medication": "MORPHINE",
              "patient_factors": [
                "COPD",
                "Home oxygen therapy"
              ]
            },
            {
              "citations": [
                "PMID:asthma005",
                "BJA 2017"
              ],
              "contraindication_reason": "Potent airway irritant causing bronchospasm in reactive airway disease",
              "evidence_grade": "B",
              "generic_name": "Desflurane",
              "justification": "Desflurane has a pungent odor and irritates airways, triggering bronchospasm in asthmatic patients. Sevoflurane is the preferred volatile agent due to its bronchodilatory properties.",
              "medication": "DESFLURANE",
              "patient_factors": [
                "Asthma",
                "Reactive airway disease"
              ]
            }
          ],
          "draw_now": [
            {
              "citations": [
                "PMID:albuterol009",
                "GINA Guidelines 2022"
              ],
              "dose": "2.5 mg nebulized",
              "evidence_grade": "A",
              "generic_name": "Albuterol",
              "indication": "First-line bronchodilator for asthma exacerbation",
              "justification": "Beta-2 selective agonist provides rapid bronchodilation with minimal cardiac effects. Essential for treating perioperative bronchospasm in asthmatic patients.",
              "medication": "ALBUTEROL",
              "patient_factors": [
                "Asthma",
                "Risk of bronchospasm"
              ]
            },
            {
              "citations": [
                "PMID:copd010",
                "GOLD Guidelines 2023"
              ],
              "dose": "2.5-5 mg nebulized",
              "evidence_grade": "A",
              "generic_name": "Albuterol",
              "indication": "Bronchodilator for COPD exacerbation",
              "justification": "Beta-2 agonists remain first-line therapy for acute COPD exacerbations. Higher doses may be needed in COPD compared to asthma due to different pathophysiology.",
              "medication": "ALBUTEROL",
              "patient_factors": [
                "COPD",
                "Home oxygen therapy"
              ]
            },
            {
              "citations": [
                "PMID:ipratropium011",
                "Thorax 2021"
              ],
              "dose": "0.5 mg nebulized",
              "evidence_grade": "A",
              "generic_name": "Ipratropium",
              "indication": "Anticholinergic bronchodilator - synergistic with albuterol in COPD",
              "justification": "Anticholinergics are particularly effective in COPD due to increased cholinergic tone. Combined with beta-2 agonists, provides superior bronchodilation compared to either agent alone.",
              "medication": "IPRATROPIUM",
              "patient_factors": [
                "COPD",
                "Chronic bronchitis component"
              ]
            }
          ],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.07000000029802322,
              "baseline_risk": 0.07000000029802322,
              "category": "cardiovascular",
              "evidence_grade": "C",
              "outcome": "VENTRICULAR_ARRHYTHMIA",
              "outcome_label": "Ventricular tachycardia/fibrillation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "7.0% risk of ventricular tachycardia/fibrillation",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk": 0.07000000029802322
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 3,
            "total_risk_factors": 6
          }
        }
      }
    },
    {
      "case_id": "ATC002",
      "success": true,
      "latency_ms": 2419.8246002197266,
      "parsing_accuracy": 0.5,
      "medication_accuracy": 0.28571428571428575,
      "risk_assessment_quality": 0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [
              {
                "citations": [
                  "PMID:etomidate016",
                  "Heart Failure Reviews 2019"
                ],
                "dose": "0.2-0.3 mg/kg IV",
                "evidence_grade": "B",
                "generic_name": "Etomidate",
                "indication": "Hemodynamically stable induction agent",
                "justification": "Etomidate provides excellent hemodynamic stability with minimal effects on cardiac output and blood pressure. Ideal for heart failure patients who cannot tolerate propofol's negative inotropic effects.",
                "medication": "ETOMIDATE",
                "patient_factors": [
                  "Heart failure",
                  "Hemodynamic instability"
                ]
              }
            ],
            "contraindicated": [
              {
                "citations": [
                  "PMID:hf001",
                  "ASA Guidelines 2020"
                ],
                "contraindication_reason": "Increases myocardial oxygen demand and arrhythmia risk in heart failure patients",
                "evidence_grade": "B",
                "generic_name": "Epinephrine",
                "justification": "Epinephrine's beta-1 effects increase heart rate and contractility, worsening the supply-demand mismatch in failing hearts. Phenylephrine is preferred for vasopressor support.",
                "medication": "EPINEPHRINE",
                "patient_factors": [
                  "Heart failure with reduced EF"
                ]
              }
            ],
            "draw_now": [
              {
                "citations": [
                  "PMID:phenyl007",
                  "ESC Guidelines 2021"
                ],
                "dose": "100-200 mcg bolus, 0.5-2 mcg/kg/min infusion",
                "evidence_grade": "A",
                "generic_name": "Phenylephrine",
                "indication": "First-line vasopressor for heart failure patients",
                "justification": "Pure alpha-agonist provides vasoconstriction without increasing heart rate or contractility, ideal for heart failure patients who cannot tolerate increased myocardial oxygen demand.",
                "medication": "PHENYLEPHRINE",
                "patient_factors": [
                  "Heart failure",
                  "Need to avoid tachycardia"
                ]
              },
              {
                "citations": [
                  "PMID:norepi008",
                  "Circulation 2020"
                ],
                "dose": "0.05-2 mcg/kg/min infusion",
                "evidence_grade": "A",
                "generic_name": "Norepinephrine",
                "indication": "Severe heart failure with cardiogenic shock",
                "justification": "Combined alpha/beta agonist provides both inotropic and vasopressor support in cardiogenic shock. Preferred over epinephrine due to less chronotropic effect and arrhythmogenicity.",
                "medication": "NOREPINEPHRINE",
                "patient_factors": [
                  "Severe heart failure",
                  "Cardiogenic shock"
                ]
              }
            ],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 1.0,
            "demographics": {
              "age_category": "AGE_1_5",
              "age_text": "18-month-old",
              "age_years": 1.5,
              "procedure": "ADENOIDECTOMY",
              "sex": "SEX_FEMALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "heart failure",
                "plain_label": "Congestive heart failure",
                "severity_weight": 1.0,
                "token": "HEART_FAILURE"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:02.074776"
          },
          "recommendations": {
            "intraoperative": [
              {
                "action": "Sevoflurane mask induction + TIVA maintenance",
                "category": "Pediatric Anesthesia",
                "evidence": "Grade A - Pediatric Anesthesia Society Guidelines",
                "priority": "moderate",
                "rationale": "Reduce emergence delirium in children"
              }
            ],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": []
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\u2695\ufe0f</span>\n                        Intra-operative Management\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Pediatric Anesthesia</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Sevoflurane mask induction + TIVA maintenance\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Reduce emergence delirium in children\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - Pediatric Anesthesia Society Guidelines\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              },
              {
                "adjusted_risk": 0.0012000000569969416,
                "baseline_risk": 0.0012000000569969416,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Pulmonary aspiration",
                    "risk": 0.0012000000569969416
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                },
                {
                  "label": "0.1% risk of pulmonary aspiration",
                  "outcome": "ASPIRATION",
                  "outcome_label": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 4,
              "total_risk_factors": 1
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [
          "HEART_FAILURE"
        ],
        "recommended_medications": {
          "consider": [
            {
              "citations": [
                "PMID:etomidate016",
                "Heart Failure Reviews 2019"
              ],
              "dose": "0.2-0.3 mg/kg IV",
              "evidence_grade": "B",
              "generic_name": "Etomidate",
              "indication": "Hemodynamically stable induction agent",
              "justification": "Etomidate provides excellent hemodynamic stability with minimal effects on cardiac output and blood pressure. Ideal for heart failure patients who cannot tolerate propofol's negative inotropic effects.",
              "medication": "ETOMIDATE",
              "patient_factors": [
                "Heart failure",
                "Hemodynamic instability"
              ]
            }
          ],
          "contraindicated": [
            {
              "citations": [
                "PMID:hf001",
                "ASA Guidelines 2020"
              ],
              "contraindication_reason": "Increases myocardial oxygen demand and arrhythmia risk in heart failure patients",
              "evidence_grade": "B",
              "generic_name": "Epinephrine",
              "justification": "Epinephrine's beta-1 effects increase heart rate and contractility, worsening the supply-demand mismatch in failing hearts. Phenylephrine is preferred for vasopressor support.",
              "medication": "EPINEPHRINE",
              "patient_factors": [
                "Heart failure with reduced EF"
              ]
            }
          ],
          "draw_now": [
            {
              "citations": [
                "PMID:phenyl007",
                "ESC Guidelines 2021"
              ],
              "dose": "100-200 mcg bolus, 0.5-2 mcg/kg/min infusion",
              "evidence_grade": "A",
              "generic_name": "Phenylephrine",
              "indication": "First-line vasopressor for heart failure patients",
              "justification": "Pure alpha-agonist provides vasoconstriction without increasing heart rate or contractility, ideal for heart failure patients who cannot tolerate increased myocardial oxygen demand.",
              "medication": "PHENYLEPHRINE",
              "patient_factors": [
                "Heart failure",
                "Need to avoid tachycardia"
              ]
            },
            {
              "citations": [
                "PMID:norepi008",
                "Circulation 2020"
              ],
              "dose": "0.05-2 mcg/kg/min infusion",
              "evidence_grade": "A",
              "generic_name": "Norepinephrine",
              "indication": "Severe heart failure with cardiogenic shock",
              "justification": "Combined alpha/beta agonist provides both inotropic and vasopressor support in cardiogenic shock. Preferred over epinephrine due to less chronotropic effect and arrhythmogenicity.",
              "medication": "NOREPINEPHRINE",
              "patient_factors": [
                "Severe heart failure",
                "Cardiogenic shock"
              ]
            }
          ],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            },
            {
              "adjusted_risk": 0.0012000000569969416,
              "baseline_risk": 0.0012000000569969416,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "ASPIRATION",
              "outcome_label": "Pulmonary aspiration",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              },
              {
                "label": "0.1% risk of pulmonary aspiration",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk": 0.0012000000569969416
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 4,
            "total_risk_factors": 1
          }
        }
      }
    },
    {
      "case_id": "ATC016",
      "success": true,
      "latency_ms": 3148.359537124634,
      "parsing_accuracy": 0.8,
      "medication_accuracy": 0.8571428571428571,
      "risk_assessment_quality": 0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [
              {
                "citations": [
                  "PMID:cisatra015",
                  "Kidney International 2020"
                ],
                "dose": "0.15-0.2 mg/kg IV",
                "evidence_grade": "A",
                "generic_name": "Cisatracurium",
                "indication": "Renal-friendly muscle relaxant",
                "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
                "medication": "CISATRACURIUM",
                "patient_factors": [
                  "CKD",
                  "Need to avoid renal-dependent drugs"
                ]
              }
            ],
            "contraindicated": [
              {
                "citations": [
                  "PMID:kidney003",
                  "KDIGO Guidelines 2021"
                ],
                "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
                "evidence_grade": "A",
                "generic_name": "NSAIDs (ketorolac, ibuprofen)",
                "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
                "medication": "NSAIDS",
                "patient_factors": [
                  "CKD stage 3+",
                  "Reduced eGFR"
                ]
              },
              {
                "citations": [
                  "PMID:hyperK004",
                  "Anesthesiology 2019"
                ],
                "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
                "evidence_grade": "B",
                "generic_name": "Succinylcholine",
                "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
                "medication": "SUCCINYLCHOLINE",
                "patient_factors": [
                  "CKD",
                  "Baseline hyperkalemia risk"
                ]
              }
            ],
            "draw_now": [
              {
                "citations": [
                  "PMID:glucose012",
                  "ADA Guidelines 2023"
                ],
                "dose": "25-50 mL IV (12.5-25g glucose)",
                "evidence_grade": "A",
                "generic_name": "Dextrose 50%",
                "indication": "Immediate hypoglycemia treatment",
                "justification": "Diabetic patients on insulin are at high risk for perioperative hypoglycemia due to NPO status and surgical stress. D50 provides rapid glucose correction.",
                "medication": "DEXTROSE_50",
                "patient_factors": [
                  "Diabetes",
                  "Insulin therapy",
                  "NPO status"
                ]
              }
            ],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 0.9633333333333333,
            "demographics": {
              "age_category": "AGE_ELDERLY",
              "age_text": "65-year-old",
              "age_years": 65,
              "sex": "SEX_MALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [
              {
                "category": "endocrine",
                "confidence": 0.8,
                "evidence_text": "diabetes",
                "plain_label": "Diabetes mellitus",
                "severity_weight": 1.0,
                "token": "DIABETES"
              },
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "hypertension",
                "plain_label": "Hypertension",
                "severity_weight": 1.0,
                "token": "HYPERTENSION"
              },
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "coronary artery disease",
                "plain_label": "Coronary artery disease",
                "severity_weight": 1.0,
                "token": "CORONARY_ARTERY_DISEASE"
              },
              {
                "category": "renal",
                "confidence": 0.8,
                "evidence_text": "chronic kidney disease",
                "plain_label": "Chronic kidney disease",
                "severity_weight": 1.0,
                "token": "CHRONIC_KIDNEY_DISEASE"
              },
              {
                "category": "pharmacological",
                "confidence": 0.85,
                "evidence_text": "lisinopril",
                "plain_label": "ACE Inhibitor (lisinopril)",
                "severity_weight": 1.0,
                "token": "ACE_INHIBITORS"
              },
              {
                "category": "pharmacological",
                "confidence": 0.85,
                "evidence_text": "metformin",
                "plain_label": "Diabetes Medication (metformin)",
                "severity_weight": 1.0,
                "token": "DIABETES_MEDICATIONS"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:04.998300"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Hourly glucose checks + continuous glucose monitoring",
                "category": "Glucose Monitoring",
                "evidence": "Grade B - Society for Ambulatory Anesthesia",
                "priority": "moderate",
                "rationale": "Prevent hypo/hyperglycemic complications"
              },
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [
              {
                "action": "Early mobilization + delirium screening protocols",
                "category": "Geriatric Care",
                "evidence": "Grade A - Enhanced Recovery Guidelines",
                "priority": "moderate",
                "rationale": "Prevent common geriatric complications"
              }
            ],
            "preoperative": [
              {
                "action": "Perioperative glucose protocol + endocrine consult",
                "category": "Glucose Management",
                "evidence": "Grade A - ADA Perioperative Guidelines",
                "priority": "high",
                "rationale": "Diabetic patients require specialized glucose management"
              },
              {
                "action": "Continue antihypertensives + BP optimization",
                "category": "BP Management",
                "evidence": "Grade A - ESC/ESA Guidelines 2014",
                "priority": "moderate",
                "rationale": "Maintain perioperative cardiovascular stability"
              },
              {
                "action": "Comprehensive geriatric assessment + frailty screening",
                "category": "Geriatric Assessment",
                "evidence": "Grade B - AGS Perioperative Guidelines",
                "priority": "moderate",
                "rationale": "Elderly patients benefit from multidisciplinary evaluation"
              }
            ]
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udccb</span>\n                        Pre-operative Optimization\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Glucose Management</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Perioperative glucose protocol + endocrine consult\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Diabetic patients require specialized glucose management\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - ADA Perioperative Guidelines\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">BP Management</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Continue antihypertensives + BP optimization\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Maintain perioperative cardiovascular stability\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - ESC/ESA Guidelines 2014\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Geriatric Assessment</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Comprehensive geriatric assessment + frailty screening\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Elderly patients benefit from multidisciplinary evaluation\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade B - AGS Perioperative Guidelines\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Glucose Monitoring</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Hourly glucose checks + continuous glucose monitoring\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Prevent hypo/hyperglycemic complications\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade B - Society for Ambulatory Anesthesia\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83c\udfe5</span>\n                        Post-operative Care\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Geriatric Care</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Early mobilization + delirium screening protocols\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Prevent common geriatric complications\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - Enhanced Recovery Guidelines\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 4,
              "total_risk_factors": 6
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [
          "DIABETES",
          "HYPERTENSION",
          "CORONARY_ARTERY_DISEASE",
          "CHRONIC_KIDNEY_DISEASE",
          "ACE_INHIBITORS",
          "DIABETES_MEDICATIONS"
        ],
        "recommended_medications": {
          "consider": [
            {
              "citations": [
                "PMID:cisatra015",
                "Kidney International 2020"
              ],
              "dose": "0.15-0.2 mg/kg IV",
              "evidence_grade": "A",
              "generic_name": "Cisatracurium",
              "indication": "Renal-friendly muscle relaxant",
              "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
              "medication": "CISATRACURIUM",
              "patient_factors": [
                "CKD",
                "Need to avoid renal-dependent drugs"
              ]
            }
          ],
          "contraindicated": [
            {
              "citations": [
                "PMID:kidney003",
                "KDIGO Guidelines 2021"
              ],
              "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
              "evidence_grade": "A",
              "generic_name": "NSAIDs (ketorolac, ibuprofen)",
              "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
              "medication": "NSAIDS",
              "patient_factors": [
                "CKD stage 3+",
                "Reduced eGFR"
              ]
            },
            {
              "citations": [
                "PMID:hyperK004",
                "Anesthesiology 2019"
              ],
              "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
              "evidence_grade": "B",
              "generic_name": "Succinylcholine",
              "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
              "medication": "SUCCINYLCHOLINE",
              "patient_factors": [
                "CKD",
                "Baseline hyperkalemia risk"
              ]
            }
          ],
          "draw_now": [
            {
              "citations": [
                "PMID:glucose012",
                "ADA Guidelines 2023"
              ],
              "dose": "25-50 mL IV (12.5-25g glucose)",
              "evidence_grade": "A",
              "generic_name": "Dextrose 50%",
              "indication": "Immediate hypoglycemia treatment",
              "justification": "Diabetic patients on insulin are at high risk for perioperative hypoglycemia due to NPO status and surgical stress. D50 provides rapid glucose correction.",
              "medication": "DEXTROSE_50",
              "patient_factors": [
                "Diabetes",
                "Insulin therapy",
                "NPO status"
              ]
            }
          ],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 4,
            "total_risk_factors": 6
          }
        }
      }
    },
    {
      "case_id": "ATC017",
      "success": true,
      "latency_ms": 2511.4781856536865,
      "parsing_accuracy": 0.5,
      "medication_accuracy": 0,
      "risk_assessment_quality": 0,
      "safety_compliance": false,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [],
            "contraindicated": [],
            "draw_now": [],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 0.96,
            "demographics": {
              "age_category": "AGE_ADULT_MIDDLE",
              "age_text": "58-year-old",
              "age_years": 58,
              "sex": "SEX_FEMALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "hypertension",
                "plain_label": "Hypertension",
                "severity_weight": 1.0,
                "token": "HYPERTENSION"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:08.640239"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": [
              {
                "action": "Continue antihypertensives + BP optimization",
                "category": "BP Management",
                "evidence": "Grade A - ESC/ESA Guidelines 2014",
                "priority": "moderate",
                "rationale": "Maintain perioperative cardiovascular stability"
              }
            ]
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udccb</span>\n                        Pre-operative Optimization\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">BP Management</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Continue antihypertensives + BP optimization\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Maintain perioperative cardiovascular stability\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - ESC/ESA Guidelines 2014\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 4,
              "total_risk_factors": 1
            }
          }
        },
        "safety_violations": [
          "Complex case with no drug interaction warnings"
        ],
        "extracted_conditions": [
          "HYPERTENSION"
        ],
        "recommended_medications": {
          "consider": [],
          "contraindicated": [],
          "draw_now": [],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 4,
            "total_risk_factors": 1
          }
        }
      }
    },
    {
      "case_id": "ATC036",
      "success": true,
      "latency_ms": 2787.262201309204,
      "parsing_accuracy": 0.4,
      "medication_accuracy": 0,
      "risk_assessment_quality": 0,
      "safety_compliance": false,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [],
            "contraindicated": [],
            "draw_now": [],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 0.86,
            "demographics": {
              "age_category": "AGE_ADULT_YOUNG",
              "age_text": "32-year-old",
              "age_years": 32,
              "urgency": "EMERGENCY"
            },
            "extracted_factors": [
              {
                "category": "demographics",
                "confidence": 0.8,
                "evidence_text": "36 weeks gestation",
                "plain_label": "Prematurity",
                "severity_weight": 1.0,
                "token": "PREMATURITY"
              },
              {
                "category": "demographics",
                "confidence": 0.8,
                "evidence_text": "weeks gestation",
                "plain_label": "Pregnancy",
                "severity_weight": 1.0,
                "token": "PREGNANCY"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:11.634942"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": []
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.07000000029802322,
                "baseline_risk": 0.07000000029802322,
                "category": "cardiovascular",
                "evidence_grade": "C",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Ventricular tachycardia/fibrillation",
                    "risk": 0.07000000029802322
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              },
              {
                "adjusted_risk": 0.0012000000569969416,
                "baseline_risk": 0.0012000000569969416,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Pulmonary aspiration",
                    "risk": 0.0012000000569969416
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "7.0% risk of ventricular tachycardia/fibrillation",
                  "outcome": "VENTRICULAR_ARRHYTHMIA",
                  "outcome_label": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 6,
              "total_risk_factors": 2
            }
          }
        },
        "safety_violations": [
          "Complex case with no drug interaction warnings"
        ],
        "extracted_conditions": [
          "PREMATURITY",
          "PREGNANCY"
        ],
        "recommended_medications": {
          "consider": [],
          "contraindicated": [],
          "draw_now": [],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.07000000029802322,
              "baseline_risk": 0.07000000029802322,
              "category": "cardiovascular",
              "evidence_grade": "C",
              "outcome": "VENTRICULAR_ARRHYTHMIA",
              "outcome_label": "Ventricular tachycardia/fibrillation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            },
            {
              "adjusted_risk": 0.0012000000569969416,
              "baseline_risk": 0.0012000000569969416,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "ASPIRATION",
              "outcome_label": "Pulmonary aspiration",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "7.0% risk of ventricular tachycardia/fibrillation",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk": 0.07000000029802322
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 6,
            "total_risk_factors": 2
          }
        }
      }
    },
    {
      "case_id": "ATC051",
      "success": true,
      "latency_ms": 2716.26877784729,
      "parsing_accuracy": 0.0,
      "medication_accuracy": 0,
      "risk_assessment_quality": 0.25,
      "safety_compliance": false,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [],
            "contraindicated": [],
            "draw_now": [],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 0.7999999999999999,
            "demographics": {
              "age_category": "AGE_ADULT_YOUNG",
              "age_text": "25-year-old",
              "age_years": 25,
              "sex": "SEX_MALE",
              "urgency": "EMERGENCY"
            },
            "extracted_factors": [],
            "session_id": "hpi_2025-09-18T23:15:15.115893"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": []
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.07000000029802322,
                "baseline_risk": 0.07000000029802322,
                "category": "cardiovascular",
                "evidence_grade": "C",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Ventricular tachycardia/fibrillation",
                    "risk": 0.07000000029802322
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              },
              {
                "adjusted_risk": 0.0012000000569969416,
                "baseline_risk": 0.0012000000569969416,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Pulmonary aspiration",
                    "risk": 0.0012000000569969416
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "7.0% risk of ventricular tachycardia/fibrillation",
                  "outcome": "VENTRICULAR_ARRHYTHMIA",
                  "outcome_label": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 6,
              "total_risk_factors": 0
            }
          }
        },
        "safety_violations": [
          "Complex case with no drug interaction warnings"
        ],
        "extracted_conditions": [],
        "recommended_medications": {
          "consider": [],
          "contraindicated": [],
          "draw_now": [],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.07000000029802322,
              "baseline_risk": 0.07000000029802322,
              "category": "cardiovascular",
              "evidence_grade": "C",
              "outcome": "VENTRICULAR_ARRHYTHMIA",
              "outcome_label": "Ventricular tachycardia/fibrillation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            },
            {
              "adjusted_risk": 0.0012000000569969416,
              "baseline_risk": 0.0012000000569969416,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "ASPIRATION",
              "outcome_label": "Pulmonary aspiration",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "7.0% risk of ventricular tachycardia/fibrillation",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk": 0.07000000029802322
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 6,
            "total_risk_factors": 0
          }
        }
      }
    },
    {
      "case_id": "ATC061",
      "success": true,
      "latency_ms": 2778.306484222412,
      "parsing_accuracy": 0.5714285714285715,
      "medication_accuracy": 0.25,
      "risk_assessment_quality": 0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [
              {
                "citations": [
                  "PMID:cisatra015",
                  "Kidney International 2020"
                ],
                "dose": "0.15-0.2 mg/kg IV",
                "evidence_grade": "A",
                "generic_name": "Cisatracurium",
                "indication": "Renal-friendly muscle relaxant",
                "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
                "medication": "CISATRACURIUM",
                "patient_factors": [
                  "CKD",
                  "Need to avoid renal-dependent drugs"
                ]
              },
              {
                "citations": [
                  "PMID:etomidate016",
                  "Heart Failure Reviews 2019"
                ],
                "dose": "0.2-0.3 mg/kg IV",
                "evidence_grade": "B",
                "generic_name": "Etomidate",
                "indication": "Hemodynamically stable induction agent",
                "justification": "Etomidate provides excellent hemodynamic stability with minimal effects on cardiac output and blood pressure. Ideal for heart failure patients who cannot tolerate propofol's negative inotropic effects.",
                "medication": "ETOMIDATE",
                "patient_factors": [
                  "Heart failure",
                  "Hemodynamic instability"
                ]
              }
            ],
            "contraindicated": [
              {
                "citations": [
                  "PMID:hf001",
                  "ASA Guidelines 2020"
                ],
                "contraindication_reason": "Increases myocardial oxygen demand and arrhythmia risk in heart failure patients",
                "evidence_grade": "B",
                "generic_name": "Epinephrine",
                "justification": "Epinephrine's beta-1 effects increase heart rate and contractility, worsening the supply-demand mismatch in failing hearts. Phenylephrine is preferred for vasopressor support.",
                "medication": "EPINEPHRINE",
                "patient_factors": [
                  "Heart failure with reduced EF"
                ]
              },
              {
                "citations": [
                  "PMID:kidney003",
                  "KDIGO Guidelines 2021"
                ],
                "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
                "evidence_grade": "A",
                "generic_name": "NSAIDs (ketorolac, ibuprofen)",
                "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
                "medication": "NSAIDS",
                "patient_factors": [
                  "CKD stage 3+",
                  "Reduced eGFR"
                ]
              },
              {
                "citations": [
                  "PMID:hyperK004",
                  "Anesthesiology 2019"
                ],
                "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
                "evidence_grade": "B",
                "generic_name": "Succinylcholine",
                "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
                "medication": "SUCCINYLCHOLINE",
                "patient_factors": [
                  "CKD",
                  "Baseline hyperkalemia risk"
                ]
              }
            ],
            "draw_now": [
              {
                "citations": [
                  "PMID:phenyl007",
                  "ESC Guidelines 2021"
                ],
                "dose": "100-200 mcg bolus, 0.5-2 mcg/kg/min infusion",
                "evidence_grade": "A",
                "generic_name": "Phenylephrine",
                "indication": "First-line vasopressor for heart failure patients",
                "justification": "Pure alpha-agonist provides vasoconstriction without increasing heart rate or contractility, ideal for heart failure patients who cannot tolerate increased myocardial oxygen demand.",
                "medication": "PHENYLEPHRINE",
                "patient_factors": [
                  "Heart failure",
                  "Need to avoid tachycardia"
                ]
              },
              {
                "citations": [
                  "PMID:norepi008",
                  "Circulation 2020"
                ],
                "dose": "0.05-2 mcg/kg/min infusion",
                "evidence_grade": "A",
                "generic_name": "Norepinephrine",
                "indication": "Severe heart failure with cardiogenic shock",
                "justification": "Combined alpha/beta agonist provides both inotropic and vasopressor support in cardiogenic shock. Preferred over epinephrine due to less chronotropic effect and arrhythmogenicity.",
                "medication": "NOREPINEPHRINE",
                "patient_factors": [
                  "Severe heart failure",
                  "Cardiogenic shock"
                ]
              }
            ],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 1.0,
            "demographics": {
              "age_category": "AGE_VERY_ELDERLY",
              "age_text": "89-year-old",
              "age_years": 89,
              "procedure": "BLEEDING_DISORDER",
              "sex": "SEX_FEMALE",
              "urgency": "ELECTIVE",
              "weight_kg": 45.0
            },
            "extracted_factors": [
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "heart failure",
                "plain_label": "Congestive heart failure",
                "severity_weight": 1.0,
                "token": "HEART_FAILURE"
              },
              {
                "category": "renal",
                "confidence": 0.8,
                "evidence_text": "chronic kidney disease",
                "plain_label": "Chronic kidney disease",
                "severity_weight": 1.0,
                "token": "CHRONIC_KIDNEY_DISEASE"
              },
              {
                "category": "pharmacological",
                "confidence": 0.85,
                "evidence_text": "warfarin",
                "plain_label": "Anticoagulant (warfarin)",
                "severity_weight": 1.2,
                "token": "ANTICOAGULANTS"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:18.184302"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": []
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              },
              {
                "adjusted_risk": 0.0012000000569969416,
                "baseline_risk": 0.0012000000569969416,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Pulmonary aspiration",
                    "risk": 0.0012000000569969416
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                },
                {
                  "label": "0.1% risk of pulmonary aspiration",
                  "outcome": "ASPIRATION",
                  "outcome_label": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 4,
              "total_risk_factors": 3
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [
          "HEART_FAILURE",
          "CHRONIC_KIDNEY_DISEASE",
          "ANTICOAGULANTS"
        ],
        "recommended_medications": {
          "consider": [
            {
              "citations": [
                "PMID:cisatra015",
                "Kidney International 2020"
              ],
              "dose": "0.15-0.2 mg/kg IV",
              "evidence_grade": "A",
              "generic_name": "Cisatracurium",
              "indication": "Renal-friendly muscle relaxant",
              "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
              "medication": "CISATRACURIUM",
              "patient_factors": [
                "CKD",
                "Need to avoid renal-dependent drugs"
              ]
            },
            {
              "citations": [
                "PMID:etomidate016",
                "Heart Failure Reviews 2019"
              ],
              "dose": "0.2-0.3 mg/kg IV",
              "evidence_grade": "B",
              "generic_name": "Etomidate",
              "indication": "Hemodynamically stable induction agent",
              "justification": "Etomidate provides excellent hemodynamic stability with minimal effects on cardiac output and blood pressure. Ideal for heart failure patients who cannot tolerate propofol's negative inotropic effects.",
              "medication": "ETOMIDATE",
              "patient_factors": [
                "Heart failure",
                "Hemodynamic instability"
              ]
            }
          ],
          "contraindicated": [
            {
              "citations": [
                "PMID:hf001",
                "ASA Guidelines 2020"
              ],
              "contraindication_reason": "Increases myocardial oxygen demand and arrhythmia risk in heart failure patients",
              "evidence_grade": "B",
              "generic_name": "Epinephrine",
              "justification": "Epinephrine's beta-1 effects increase heart rate and contractility, worsening the supply-demand mismatch in failing hearts. Phenylephrine is preferred for vasopressor support.",
              "medication": "EPINEPHRINE",
              "patient_factors": [
                "Heart failure with reduced EF"
              ]
            },
            {
              "citations": [
                "PMID:kidney003",
                "KDIGO Guidelines 2021"
              ],
              "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
              "evidence_grade": "A",
              "generic_name": "NSAIDs (ketorolac, ibuprofen)",
              "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
              "medication": "NSAIDS",
              "patient_factors": [
                "CKD stage 3+",
                "Reduced eGFR"
              ]
            },
            {
              "citations": [
                "PMID:hyperK004",
                "Anesthesiology 2019"
              ],
              "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
              "evidence_grade": "B",
              "generic_name": "Succinylcholine",
              "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
              "medication": "SUCCINYLCHOLINE",
              "patient_factors": [
                "CKD",
                "Baseline hyperkalemia risk"
              ]
            }
          ],
          "draw_now": [
            {
              "citations": [
                "PMID:phenyl007",
                "ESC Guidelines 2021"
              ],
              "dose": "100-200 mcg bolus, 0.5-2 mcg/kg/min infusion",
              "evidence_grade": "A",
              "generic_name": "Phenylephrine",
              "indication": "First-line vasopressor for heart failure patients",
              "justification": "Pure alpha-agonist provides vasoconstriction without increasing heart rate or contractility, ideal for heart failure patients who cannot tolerate increased myocardial oxygen demand.",
              "medication": "PHENYLEPHRINE",
              "patient_factors": [
                "Heart failure",
                "Need to avoid tachycardia"
              ]
            },
            {
              "citations": [
                "PMID:norepi008",
                "Circulation 2020"
              ],
              "dose": "0.05-2 mcg/kg/min infusion",
              "evidence_grade": "A",
              "generic_name": "Norepinephrine",
              "indication": "Severe heart failure with cardiogenic shock",
              "justification": "Combined alpha/beta agonist provides both inotropic and vasopressor support in cardiogenic shock. Preferred over epinephrine due to less chronotropic effect and arrhythmogenicity.",
              "medication": "NOREPINEPHRINE",
              "patient_factors": [
                "Severe heart failure",
                "Cardiogenic shock"
              ]
            }
          ],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            },
            {
              "adjusted_risk": 0.0012000000569969416,
              "baseline_risk": 0.0012000000569969416,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "ASPIRATION",
              "outcome_label": "Pulmonary aspiration",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              },
              {
                "label": "0.1% risk of pulmonary aspiration",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk": 0.0012000000569969416
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 4,
            "total_risk_factors": 3
          }
        }
      }
    },
    {
      "case_id": "ATC076",
      "success": true,
      "latency_ms": 2987.541913986206,
      "parsing_accuracy": 0.28571428571428575,
      "medication_accuracy": 0.3333333333333333,
      "risk_assessment_quality": 0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [
              {
                "citations": [
                  "PMID:cisatra015",
                  "Kidney International 2020"
                ],
                "dose": "0.15-0.2 mg/kg IV",
                "evidence_grade": "A",
                "generic_name": "Cisatracurium",
                "indication": "Renal-friendly muscle relaxant",
                "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
                "medication": "CISATRACURIUM",
                "patient_factors": [
                  "CKD",
                  "Need to avoid renal-dependent drugs"
                ]
              }
            ],
            "contraindicated": [
              {
                "citations": [
                  "PMID:kidney003",
                  "KDIGO Guidelines 2021"
                ],
                "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
                "evidence_grade": "A",
                "generic_name": "NSAIDs (ketorolac, ibuprofen)",
                "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
                "medication": "NSAIDS",
                "patient_factors": [
                  "CKD stage 3+",
                  "Reduced eGFR"
                ]
              },
              {
                "citations": [
                  "PMID:hyperK004",
                  "Anesthesiology 2019"
                ],
                "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
                "evidence_grade": "B",
                "generic_name": "Succinylcholine",
                "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
                "medication": "SUCCINYLCHOLINE",
                "patient_factors": [
                  "CKD",
                  "Baseline hyperkalemia risk"
                ]
              }
            ],
            "draw_now": [
              {
                "citations": [
                  "PMID:glucose012",
                  "ADA Guidelines 2023"
                ],
                "dose": "25-50 mL IV (12.5-25g glucose)",
                "evidence_grade": "A",
                "generic_name": "Dextrose 50%",
                "indication": "Immediate hypoglycemia treatment",
                "justification": "Diabetic patients on insulin are at high risk for perioperative hypoglycemia due to NPO status and surgical stress. D50 provides rapid glucose correction.",
                "medication": "DEXTROSE_50",
                "patient_factors": [
                  "Diabetes",
                  "Insulin therapy",
                  "NPO status"
                ]
              }
            ],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 1.0,
            "demographics": {
              "age_category": "AGE_ADULT_MIDDLE",
              "age_text": "52-year-old",
              "age_years": 52,
              "procedure": "LIVER_DISEASE",
              "sex": "SEX_MALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [
              {
                "category": "endocrine",
                "confidence": 0.8,
                "evidence_text": "diabetes",
                "plain_label": "Diabetes mellitus",
                "severity_weight": 1.0,
                "token": "DIABETES"
              },
              {
                "category": "cardiac",
                "confidence": 0.8,
                "evidence_text": "hypertension",
                "plain_label": "Hypertension",
                "severity_weight": 1.0,
                "token": "HYPERTENSION"
              },
              {
                "category": "renal",
                "confidence": 0.8,
                "evidence_text": "dialysis",
                "plain_label": "Chronic kidney disease",
                "severity_weight": 1.0,
                "token": "CHRONIC_KIDNEY_DISEASE"
              }
            ],
            "session_id": "hpi_2025-09-18T23:15:21.449457"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Hourly glucose checks + continuous glucose monitoring",
                "category": "Glucose Monitoring",
                "evidence": "Grade B - Society for Ambulatory Anesthesia",
                "priority": "moderate",
                "rationale": "Prevent hypo/hyperglycemic complications"
              },
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": [
              {
                "action": "Perioperative glucose protocol + endocrine consult",
                "category": "Glucose Management",
                "evidence": "Grade A - ADA Perioperative Guidelines",
                "priority": "high",
                "rationale": "Diabetic patients require specialized glucose management"
              },
              {
                "action": "Continue antihypertensives + BP optimization",
                "category": "BP Management",
                "evidence": "Grade A - ESC/ESA Guidelines 2014",
                "priority": "moderate",
                "rationale": "Maintain perioperative cardiovascular stability"
              }
            ]
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udccb</span>\n                        Pre-operative Optimization\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Glucose Management</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Perioperative glucose protocol + endocrine consult\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Diabetic patients require specialized glucose management\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - ADA Perioperative Guidelines\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">BP Management</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Continue antihypertensives + BP optimization\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Maintain perioperative cardiovascular stability\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade A - ESC/ESA Guidelines 2014\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            \n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ca8a04;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Glucose Monitoring</strong>\n                            <span style=\"\n                                background: #ca8a0420;\n                                color: #ca8a04;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">MODERATE</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Hourly glucose checks + continuous glucose monitoring\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Prevent hypo/hyperglycemic complications\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade B - Society for Ambulatory Anesthesia\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 4,
              "total_risk_factors": 3
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [
          "DIABETES",
          "HYPERTENSION",
          "CHRONIC_KIDNEY_DISEASE"
        ],
        "recommended_medications": {
          "consider": [
            {
              "citations": [
                "PMID:cisatra015",
                "Kidney International 2020"
              ],
              "dose": "0.15-0.2 mg/kg IV",
              "evidence_grade": "A",
              "generic_name": "Cisatracurium",
              "indication": "Renal-friendly muscle relaxant",
              "justification": "Cisatracurium undergoes Hofmann elimination and ester hydrolysis, making it ideal for CKD patients. No active metabolites and no dependence on renal clearance.",
              "medication": "CISATRACURIUM",
              "patient_factors": [
                "CKD",
                "Need to avoid renal-dependent drugs"
              ]
            }
          ],
          "contraindicated": [
            {
              "citations": [
                "PMID:kidney003",
                "KDIGO Guidelines 2021"
              ],
              "contraindication_reason": "Nephrotoxic - can worsen kidney function and precipitate dialysis",
              "evidence_grade": "A",
              "generic_name": "NSAIDs (ketorolac, ibuprofen)",
              "justification": "NSAIDs reduce renal blood flow via prostaglandin inhibition. In CKD patients, this can cause acute-on-chronic kidney injury requiring dialysis. Use acetaminophen or regional blocks instead.",
              "medication": "NSAIDS",
              "patient_factors": [
                "CKD stage 3+",
                "Reduced eGFR"
              ]
            },
            {
              "citations": [
                "PMID:hyperK004",
                "Anesthesiology 2019"
              ],
              "contraindication_reason": "Risk of life-threatening hyperkalemia in CKD patients",
              "evidence_grade": "B",
              "generic_name": "Succinylcholine",
              "justification": "CKD patients often have baseline hyperkalemia. Succinylcholine increases serum K+ by 0.5-1.0 mEq/L, potentially causing cardiac arrest. Rocuronium with sugammadex is safer.",
              "medication": "SUCCINYLCHOLINE",
              "patient_factors": [
                "CKD",
                "Baseline hyperkalemia risk"
              ]
            }
          ],
          "draw_now": [
            {
              "citations": [
                "PMID:glucose012",
                "ADA Guidelines 2023"
              ],
              "dose": "25-50 mL IV (12.5-25g glucose)",
              "evidence_grade": "A",
              "generic_name": "Dextrose 50%",
              "indication": "Immediate hypoglycemia treatment",
              "justification": "Diabetic patients on insulin are at high risk for perioperative hypoglycemia due to NPO status and surgical stress. D50 provides rapid glucose correction.",
              "medication": "DEXTROSE_50",
              "patient_factors": [
                "Diabetes",
                "Insulin therapy",
                "NPO status"
              ]
            }
          ],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 4,
            "total_risk_factors": 3
          }
        }
      }
    },
    {
      "case_id": "ATC091",
      "success": true,
      "latency_ms": 2596.2183475494385,
      "parsing_accuracy": 1.0,
      "medication_accuracy": 1.0,
      "risk_assessment_quality": 0.0,
      "safety_compliance": true,
      "error": null,
      "detailed_results": {
        "response": {
          "medications": {
            "consider": [],
            "contraindicated": [],
            "draw_now": [],
            "standard": [
              {
                "citations": [
                  "PMID:propofol018",
                  "ASA Guidelines 2023"
                ],
                "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
                "evidence_grade": "A",
                "generic_name": "Propofol",
                "indication": "Standard induction agent",
                "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
                "medication": "PROPOFOL",
                "patient_factors": [
                  "Standard anesthetic induction"
                ]
              },
              {
                "citations": [
                  "PMID:sevoflurane019",
                  "European Journal of Anaesthesiology 2022"
                ],
                "dose": "1-2% inspired concentration",
                "evidence_grade": "A",
                "generic_name": "Sevoflurane",
                "indication": "Standard maintenance anesthetic",
                "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
                "medication": "SEVOFLURANE",
                "patient_factors": [
                  "Standard maintenance anesthesia"
                ]
              }
            ]
          },
          "parsed": {
            "confidence_score": 0.7999999999999999,
            "demographics": {
              "age_category": "AGE_ADULT_YOUNG",
              "age_text": "28-year-old",
              "age_years": 28,
              "sex": "SEX_MALE",
              "urgency": "ELECTIVE"
            },
            "extracted_factors": [],
            "session_id": "hpi_2025-09-18T23:15:24.956375"
          },
          "recommendations": {
            "intraoperative": [],
            "monitoring": [
              {
                "action": "Consider ICU/HDU postoperative care",
                "category": "Enhanced Monitoring",
                "evidence": "Grade C - Clinical Consensus",
                "priority": "high",
                "rationale": "Multiple high-risk factors present"
              }
            ],
            "postoperative": [],
            "preoperative": []
          },
          "recommendations_html": "\n                <div class=\"recommendation-category\" style=\"margin-bottom: 1.5rem;\">\n                    <h4 style=\"color: #06b6d4; margin-bottom: 0.75rem; display: flex; align-items: center; gap: 0.5rem;\">\n                        <span style=\"font-size: 1.2rem;\">\ud83d\udcca</span>\n                        Enhanced Monitoring\n                    </h4>\n                    <div class=\"recommendation-list\">\n            \n                    <div class=\"recommendation-item\" style=\"\n                        margin-bottom: 1rem;\n                        padding: 1rem;\n                        background: rgba(255,255,255,0.02);\n                        border-radius: 8px;\n                        border-left: 3px solid #ea580c;\n                    \">\n                        <div style=\"display: flex; justify-content: between; align-items: flex-start; margin-bottom: 0.5rem;\">\n                            <strong style=\"color: #e2e8f0; font-size: 1.1rem;\">Enhanced Monitoring</strong>\n                            <span style=\"\n                                background: #ea580c20;\n                                color: #ea580c;\n                                padding: 2px 8px;\n                                border-radius: 12px;\n                                font-size: 0.75rem;\n                                font-weight: 600;\n                                margin-left: auto;\n                            \">HIGH</span>\n                        </div>\n                        <div style=\"color: #cbd5e1; font-weight: 600; margin-bottom: 0.5rem;\">\n                            Consider ICU/HDU postoperative care\n                        </div>\n                        <div style=\"color: #94a3b8; font-size: 0.9rem; margin-bottom: 0.5rem;\">\n                            <strong>Rationale:</strong> Multiple high-risk factors present\n                        </div>\n                        <div style=\"color: #64748b; font-size: 0.8rem;\">\n                            \ud83d\udcda <strong>Evidence:</strong> Grade C - Clinical Consensus\n                        </div>\n                    </div>\n                \n                    </div>\n                </div>\n            ",
          "risks": {
            "risks": [
              {
                "adjusted_risk": 0.2800000011920929,
                "baseline_risk": 0.2800000011920929,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Failed intubation",
                    "risk": 0.2800000011920929
                  }
                ]
              },
              {
                "adjusted_risk": 0.07000000029802322,
                "baseline_risk": 0.07000000029802322,
                "category": "cardiovascular",
                "evidence_grade": "C",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Ventricular tachycardia/fibrillation",
                    "risk": 0.07000000029802322
                  }
                ]
              },
              {
                "adjusted_risk": 0.044999998062849045,
                "baseline_risk": 0.044999998062849045,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "24-hour mortality",
                    "risk": 0.044999998062849045
                  }
                ]
              },
              {
                "adjusted_risk": 0.023000000044703484,
                "baseline_risk": 0.023000000044703484,
                "category": "mortality",
                "evidence_grade": "C",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "30-day mortality",
                    "risk": 0.023000000044703484
                  }
                ]
              },
              {
                "adjusted_risk": 0.0013000001199543476,
                "baseline_risk": 0.0013000001199543476,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Bronchospasm",
                    "risk": 0.0013000001199543476
                  }
                ]
              },
              {
                "adjusted_risk": 0.0012000000569969416,
                "baseline_risk": 0.0012000000569969416,
                "category": "airway",
                "evidence_grade": "C",
                "outcome": "ASPIRATION",
                "outcome_label": "Pulmonary aspiration",
                "risk_ratio": 1.0,
                "specific_outcomes": [
                  {
                    "citations": [],
                    "explanation": "Risk adjusted based on 0 contributing factors",
                    "management": "Consider evidence-based interventions",
                    "name": "Pulmonary aspiration",
                    "risk": 0.0012000000569969416
                  }
                ]
              }
            ],
            "summary": {
              "biggest_risk_increases": [],
              "highest_absolute_risks": [
                {
                  "label": "28.0% risk of failed intubation",
                  "outcome": "FAILED_INTUBATION",
                  "outcome_label": "Failed intubation",
                  "risk": 0.2800000011920929
                },
                {
                  "label": "7.0% risk of ventricular tachycardia/fibrillation",
                  "outcome": "VENTRICULAR_ARRHYTHMIA",
                  "outcome_label": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                },
                {
                  "label": "4.5% risk of 24-hour mortality",
                  "outcome": "MORTALITY_24H",
                  "outcome_label": "24-hour mortality",
                  "risk": 0.044999998062849045
                },
                {
                  "label": "2.3% risk of 30-day mortality",
                  "outcome": "MORTALITY_30D",
                  "outcome_label": "30-day mortality",
                  "risk": 0.023000000044703484
                },
                {
                  "label": "0.1% risk of bronchospasm",
                  "outcome": "BRONCHOSPASM",
                  "outcome_label": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ],
              "max_absolute_risk": 0.2800000011920929,
              "outcomes_with_evidence": 0,
              "overall_risk_score": "high",
              "total_outcomes_assessed": 6,
              "total_risk_factors": 0
            }
          }
        },
        "safety_violations": [],
        "extracted_conditions": [],
        "recommended_medications": {
          "consider": [],
          "contraindicated": [],
          "draw_now": [],
          "standard": [
            {
              "citations": [
                "PMID:propofol018",
                "ASA Guidelines 2023"
              ],
              "dose": "1-2 mg/kg IV (reduced for elderly/sick)",
              "evidence_grade": "A",
              "generic_name": "Propofol",
              "indication": "Standard induction agent",
              "justification": "Propofol remains the gold standard induction agent due to rapid onset, smooth induction, and quick recovery. Dose reduction needed in elderly and hemodynamically unstable patients.",
              "medication": "PROPOFOL",
              "patient_factors": [
                "Standard anesthetic induction"
              ]
            },
            {
              "citations": [
                "PMID:sevoflurane019",
                "European Journal of Anaesthesiology 2022"
              ],
              "dose": "1-2% inspired concentration",
              "evidence_grade": "A",
              "generic_name": "Sevoflurane",
              "indication": "Standard maintenance anesthetic",
              "justification": "Sevoflurane provides excellent anesthetic maintenance with rapid onset/offset and minimal airway irritation. Preferred volatile agent for most cases including those with reactive airways.",
              "medication": "SEVOFLURANE",
              "patient_factors": [
                "Standard maintenance anesthesia"
              ]
            }
          ]
        },
        "assessed_risks": {
          "risks": [
            {
              "adjusted_risk": 0.2800000011920929,
              "baseline_risk": 0.2800000011920929,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "FAILED_INTUBATION",
              "outcome_label": "Failed intubation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Failed intubation",
                  "risk": 0.2800000011920929
                }
              ]
            },
            {
              "adjusted_risk": 0.07000000029802322,
              "baseline_risk": 0.07000000029802322,
              "category": "cardiovascular",
              "evidence_grade": "C",
              "outcome": "VENTRICULAR_ARRHYTHMIA",
              "outcome_label": "Ventricular tachycardia/fibrillation",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Ventricular tachycardia/fibrillation",
                  "risk": 0.07000000029802322
                }
              ]
            },
            {
              "adjusted_risk": 0.044999998062849045,
              "baseline_risk": 0.044999998062849045,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_24H",
              "outcome_label": "24-hour mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "24-hour mortality",
                  "risk": 0.044999998062849045
                }
              ]
            },
            {
              "adjusted_risk": 0.023000000044703484,
              "baseline_risk": 0.023000000044703484,
              "category": "mortality",
              "evidence_grade": "C",
              "outcome": "MORTALITY_30D",
              "outcome_label": "30-day mortality",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "30-day mortality",
                  "risk": 0.023000000044703484
                }
              ]
            },
            {
              "adjusted_risk": 0.0013000001199543476,
              "baseline_risk": 0.0013000001199543476,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "BRONCHOSPASM",
              "outcome_label": "Bronchospasm",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Bronchospasm",
                  "risk": 0.0013000001199543476
                }
              ]
            },
            {
              "adjusted_risk": 0.0012000000569969416,
              "baseline_risk": 0.0012000000569969416,
              "category": "airway",
              "evidence_grade": "C",
              "outcome": "ASPIRATION",
              "outcome_label": "Pulmonary aspiration",
              "risk_ratio": 1.0,
              "specific_outcomes": [
                {
                  "citations": [],
                  "explanation": "Risk adjusted based on 0 contributing factors",
                  "management": "Consider evidence-based interventions",
                  "name": "Pulmonary aspiration",
                  "risk": 0.0012000000569969416
                }
              ]
            }
          ],
          "summary": {
            "biggest_risk_increases": [],
            "highest_absolute_risks": [
              {
                "label": "28.0% risk of failed intubation",
                "outcome": "FAILED_INTUBATION",
                "outcome_label": "Failed intubation",
                "risk": 0.2800000011920929
              },
              {
                "label": "7.0% risk of ventricular tachycardia/fibrillation",
                "outcome": "VENTRICULAR_ARRHYTHMIA",
                "outcome_label": "Ventricular tachycardia/fibrillation",
                "risk": 0.07000000029802322
              },
              {
                "label": "4.5% risk of 24-hour mortality",
                "outcome": "MORTALITY_24H",
                "outcome_label": "24-hour mortality",
                "risk": 0.044999998062849045
              },
              {
                "label": "2.3% risk of 30-day mortality",
                "outcome": "MORTALITY_30D",
                "outcome_label": "30-day mortality",
                "risk": 0.023000000044703484
              },
              {
                "label": "0.1% risk of bronchospasm",
                "outcome": "BRONCHOSPASM",
                "outcome_label": "Bronchospasm",
                "risk": 0.0013000001199543476
              }
            ],
            "max_absolute_risk": 0.2800000011920929,
            "outcomes_with_evidence": 0,
            "overall_risk_score": "high",
            "total_outcomes_assessed": 6,
            "total_risk_factors": 0
          }
        }
      }
    }
  ],
  "test_cases": [
    {
      "case_id": "ATC001",
      "name": "Pediatric tonsillectomy with asthma and recent URI",
      "specialty": "pediatric_ent",
      "hpi_text": "5-year-old boy presenting for tonsillectomy and adenoidectomy. History of asthma on daily fluticasone inhaler and albuterol PRN. Recent upper respiratory infection 2 weeks ago with persistent cough. Obstructive sleep apnea with AHI of 12.",
      "demographics": {
        "age_years": 5,
        "sex": "male",
        "weight_kg": 18
      },
      "expected_conditions": [
        "ASTHMA",
        "RECENT_URI_2W",
        "OSA"
      ],
      "expected_medications": [
        "ALBUTEROL",
        "SEVOFLURANE"
      ],
      "expected_risks": [
        "LARYNGOSPASM",
        "BRONCHOSPASM"
      ],
      "safety_critical": true,
      "complexity_score": 4
    },
    {
      "case_id": "ATC002",
      "name": "Infant adenoidectomy with Down syndrome",
      "specialty": "pediatric_ent",
      "hpi_text": "18-month-old female with Down syndrome presenting for adenoidectomy. History of recurrent otitis media, congestive heart failure managed with digoxin and furosemide. Baseline oxygen saturation 94%.",
      "demographics": {
        "age_years": 1.5,
        "sex": "female",
        "weight_kg": 10
      },
      "expected_conditions": [
        "DOWN_SYNDROME",
        "HEART_FAILURE",
        "AGE_INFANT"
      ],
      "expected_medications": [
        "CISATRACURIUM",
        "SEVOFLURANE"
      ],
      "expected_risks": [
        "DIFFICULT_INTUBATION",
        "POSTOP_DELIRIUM"
      ],
      "safety_critical": true,
      "complexity_score": 5
    },
    {
      "case_id": "ATC016",
      "name": "CABG with diabetes and CKD",
      "specialty": "adult_cardiac",
      "hpi_text": "65-year-old male with coronary artery disease status post CABG 2 years ago, diabetes mellitus type 2 on metformin and insulin, hypertension on lisinopril, chronic kidney disease stage 3, presenting for valve replacement.",
      "demographics": {
        "age_years": 65,
        "sex": "male",
        "weight_kg": 85
      },
      "expected_conditions": [
        "CORONARY_ARTERY_DISEASE",
        "DIABETES",
        "HYPERTENSION",
        "CHRONIC_KIDNEY_DISEASE"
      ],
      "expected_medications": [
        "PROPOFOL",
        "CISATRACURIUM",
        "DEXTROSE_50"
      ],
      "expected_risks": [
        "MORTALITY_INHOSPITAL",
        "ACUTE_KIDNEY_INJURY"
      ],
      "safety_critical": true,
      "complexity_score": 5
    },
    {
      "case_id": "ATC017",
      "name": "Emergency aortic dissection repair",
      "specialty": "adult_cardiac",
      "hpi_text": "58-year-old female with acute Type A aortic dissection, hemodynamically unstable, on norepinephrine drip. History of hypertension and bicuspid aortic valve. Presenting emergently for ascending aortic repair.",
      "demographics": {
        "age_years": 58,
        "sex": "female",
        "weight_kg": 70
      },
      "expected_conditions": [
        "AORTIC_DISSECTION",
        "HYPERTENSION",
        "HEMODYNAMIC_INSTABILITY"
      ],
      "expected_medications": [
        "ETOMIDATE",
        "ROCURONIUM"
      ],
      "expected_risks": [
        "MORTALITY_INHOSPITAL",
        "MASSIVE_BLEEDING"
      ],
      "safety_critical": true,
      "complexity_score": 5
    },
    {
      "case_id": "ATC036",
      "name": "Emergency C-section with preeclampsia",
      "specialty": "obstetric",
      "hpi_text": "32-year-old G2P1 at 36 weeks gestation with severe preeclampsia. Blood pressure 180/110, proteinuria 3+, visual changes. Fetal heart rate showing late decelerations. Emergency cesarean section indicated.",
      "demographics": {
        "age_years": 32,
        "sex": "female",
        "weight_kg": 75,
        "gestational_age": 36
      },
      "expected_conditions": [
        "PREECLAMPSIA",
        "PREGNANCY",
        "FETAL_DISTRESS"
      ],
      "expected_medications": [
        "PHENYLEPHRINE",
        "LABETALOL"
      ],
      "expected_risks": [
        "MATERNAL_HYPOTENSION",
        "POSTPARTUM_HEMORRHAGE"
      ],
      "safety_critical": true,
      "complexity_score": 4
    },
    {
      "case_id": "ATC051",
      "name": "Polytrauma with head injury",
      "specialty": "trauma",
      "hpi_text": "25-year-old male motorcycle accident victim with traumatic brain injury, hemopneumothorax, and femur fracture. GCS 8, hypotensive, last meal 2 hours ago. Requires emergent craniotomy and orthopedic repair.",
      "demographics": {
        "age_years": 25,
        "sex": "male",
        "weight_kg": 80
      },
      "expected_conditions": [
        "TRAUMA",
        "HEAD_INJURY",
        "FULL_STOMACH",
        "HEMOPNEUMOTHORAX"
      ],
      "expected_medications": [
        "ETOMIDATE",
        "SUCCINYLCHOLINE"
      ],
      "expected_risks": [
        "ASPIRATION",
        "MORTALITY_INHOSPITAL"
      ],
      "safety_critical": true,
      "complexity_score": 5
    },
    {
      "case_id": "ATC061",
      "name": "Hip fracture in frail elderly",
      "specialty": "geriatric",
      "hpi_text": "89-year-old female with hip fracture after fall. History of dementia, atrial fibrillation on warfarin, heart failure NYHA class III, chronic kidney disease. Weighs 45kg, frail appearance.",
      "demographics": {
        "age_years": 89,
        "sex": "female",
        "weight_kg": 45
      },
      "expected_conditions": [
        "HEART_FAILURE",
        "DEMENTIA",
        "ANTICOAGULANTS",
        "AGE_VERY_ELDERLY"
      ],
      "expected_medications": [
        "PROPOFOL",
        "ROCURONIUM"
      ],
      "expected_risks": [
        "POSTOP_DELIRIUM",
        "MORTALITY_INHOSPITAL"
      ],
      "safety_critical": true,
      "complexity_score": 4
    },
    {
      "case_id": "ATC076",
      "name": "Liver transplant with multiple comorbidities",
      "specialty": "transplant",
      "hpi_text": "52-year-old male with end-stage liver disease secondary to hepatitis C and alcohol abuse. History of portal hypertension, ascites, hepatorenal syndrome on dialysis, diabetes mellitus. Presenting for liver transplantation.",
      "demographics": {
        "age_years": 52,
        "sex": "male",
        "weight_kg": 65
      },
      "expected_conditions": [
        "LIVER_DISEASE",
        "HEPATORENAL_SYNDROME",
        "DIABETES",
        "ASCITES"
      ],
      "expected_medications": [
        "CISATRACURIUM",
        "ALBUMIN"
      ],
      "expected_risks": [
        "MASSIVE_BLEEDING",
        "ACUTE_KIDNEY_INJURY"
      ],
      "safety_critical": true,
      "complexity_score": 5
    },
    {
      "case_id": "ATC091",
      "name": "Healthy patient for arthroscopy",
      "specialty": "ambulatory",
      "hpi_text": "28-year-old athletic male presenting for arthroscopic knee surgery. No medical history, no medications, no allergies. Physical exam normal.",
      "demographics": {
        "age_years": 28,
        "sex": "male",
        "weight_kg": 75
      },
      "expected_conditions": [],
      "expected_medications": [
        "PROPOFOL",
        "SEVOFLURANE"
      ],
      "expected_risks": [],
      "safety_critical": false,
      "complexity_score": 1
    }
  ]
}